251. Determination of olprinone in human plasma utilizing liquid chromatography tandem mass spectrometry.
- Author
-
Zhu P, Wen YG, Chen JM, Zhuang J, Zhou ZL, Zheng SY, Wu RB, Xiao XJ, Lu C, Fan RX, Guo HM, and Fan XP
- Subjects
- Acetates chemistry, Calibration, Chemistry Techniques, Analytical, Chemistry, Pharmaceutical methods, Humans, Imidazoles analysis, Ions, Methylene Chloride chemistry, Phosphodiesterase 3 Inhibitors analysis, Pyridones analysis, Quality Control, Reproducibility of Results, Spectrometry, Mass, Electrospray Ionization methods, Chromatography, Liquid methods, Imidazoles blood, Imidazoles pharmacokinetics, Phosphodiesterase 3 Inhibitors blood, Phosphodiesterase 3 Inhibitors pharmacokinetics, Pyridones blood, Pyridones pharmacokinetics, Tandem Mass Spectrometry methods
- Abstract
A sensitive and rapid method was developed for quantification of olprinone in human plasma utilizing liquid chromatography tandem mass spectrometry (LC-MS/MS). An aliquot of 1 mL plasma sample was extracted with ethyl acetate-dichloromethane. Separation of olprinone and the milrinone (internal standard, IS) from the interferences was achieved on a C(18) column followed by MS/MS detection. The analytes were monitored in the positive ionization mode. Multiple reaction monitoring using the transition of m/z 251 → m/z 155 and m/z 212 → m/z 140 was performed to quantify olprinone and IS, respectively. The method had a total chromatographic run time of 3 min and linear calibration curves over the concentration range of 0.5-60 ng/mL. The lower limit of quantification (LLOQ) was 0.5 ng/mL. The intra- and inter-day precisions were less than 16.3% for low QC level, and 7.1% for other QC levels, respectively. The intra- and inter-day relative errors were ranged between -12.2% and 3.7% for three QC concentration levels. The validated method was successfully applied to the quantification of olprinone concentration in human plasma after intravenous (i.v.) administration of olprinone at a constant rate of infusion of 2 μg/(kg min) for 5 min in order to evaluate the pharmacokinetics., (Copyright © 2010 Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF